Objective: To evaluate the efficacy and safety of adjuvant transarterial chemoembolization
(TACE) after curative hepatectomy in improving the survival of patients with primary …

Purpose To retrospectively compare the outcome of combined transcatheter arterial
chemoembolization (TACE) and radiofrequency ablation (RFA)(hereafter, TACE-RFA) with …

Background Surgical resection of huge hepatocellular carcinoma (HCC,≥ 10 cm) is
potentially curative. More adjuvant treatments are needed to reduce relapses in these …

Background: Transcatheter arterial chemoembolization (TACE) is one of the local therapies
most commonly used to treat intermediate-stage or advanced-stage hepatocellular …

Background: Transarterial chemoembolization (TACE) has proven to be an effective
adjuvant therapy with liver resection (LR) to treat patients with hepatocellular carcinoma …

Background Preoperative transcatheter arterial chemoembolization (TACE) is administered
to improve long-term outcome after surgical resection of hepatocellular carcinoma (HCC) …

Aim: The efficacy of transarterial chemoembolization (TACE) for inoperable hepatocellular
carcinoma (HCC) is positive, but for postoperative HCC, many studies have reported …

Background Debate continues about the benefits of preoperative transarterial
chemoembolization (TACE) for treatment of hepatocellular carcinoma (HCC). This study …

Background The aim of this study was to systematically evaluate and determine those
patients with hepatocellular carcinoma (HCC) that would benefit from the administration of …

Background & Aims: We compared the efficacy of transcatheter arterial chemoembolization
(TACE) in combination with CT-guided radiofrequency ablation (RFA) with that of surgical …